AbbVie Inc. officer Hudson Thomas J is set to sell 49,170 shares of the company's common stock, with an aggregate market value of approximately $9,297,210.37. The sale is scheduled for 08/08/2024, which coincides with the date Hudson acquired the shares through a stock option exercise as part of his compensation from the issuer. This transaction follows a significant sale of 101,886 shares in the past three months, which grossed over $19 million.

AbbVie Inc. officer Hudson Thomas J is set to sell 49,170 shares of the company's common stock, with an aggregate market value of approximately $9,297,210.37. The sale is scheduled for 08/08/2024, which coincides with the date Hudson acquired the shares through a stock option exercise as part of his compensation from the issuer. This transaction follows a significant sale of 101,886 shares in the past three months, which grossed over $19 million.